Download our NEW Mobile App!
Diabetes Resource Centre Logo

Patient Resources

Get Healthy!

  • Posted June 23, 2025

GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds

In a new observational study, patients with migraine given a daily dose of liraglutide, a popular GLP-1 receptor agonist, reported significantly fewer headache days and an improved quality of life.

Health News is provided as a service to Diabetes Resource Centre site users by HealthDay. Diabetes Resource Centre nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.

Share

Tags